Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
2130.9000 14.60 (0.69%)
NSE Sep 10, 2025 15:31 PM
Volume: 773.7K
 

announcement
Conference/Earnings Calls Alerts
logo
Glenmark Pharmaceuticals Ltd.
31 May 2021
2130.90
0.69%
Earnings Call for Q4FY21 of Glenmark Pharmaceuticals

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.

video
 
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes higher, IDBI Bank files an insolvency case against Zee Entertainment
Trendlyne Marketwatch | 10 Sep 2025, 04:02PM
Five stocks to buy from analysts this week - September 9, 2025
The Baseline | 09 Sep 2025, 05:38PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
| 29 Jun 2020